论文部分内容阅读
多胺是指腐胺、精脒、精胺等一类含两个或多个胺基的脂肪族化合物。广泛存在于生物体内,是机体某些氨基酸脱羧后的产物,与生物体的核酸、蛋白质代谢及细胞发育繁殖密切相关.恶性肿瘤患者体液中多胺含量增高,尿中多胺的排出量显著增多,当肿瘤切除或治疗后,多胺含量即下降,肿瘤复发时含量又上升。目前认为,作为恶性肿瘤的辅助诊断及疗效观察,多胺是一项较好的指标。材料与方法 1.测定对象:对照组为33名我院女性健康医护人员,年龄19～53岁。观察组为乳腺癌患者42例,全为女性,均经临床、细胞学和病理切片证实,年龄31～61岁.
Polyamine refers to a family of fatty compounds containing two or more amine groups such as putrescine, spermidine, and spermine. Extensive in the body, it is the product of decarboxylation of certain amino acids in the body. It is closely related to the nucleic acid, protein metabolism and cell development and reproduction of organisms. The content of polyamines in the body fluids of patients with malignant tumors increases, and the output of polyamines in urine increases significantly. When the tumor is removed or treated, the polyamine content decreases and the tumor rises again when the tumor recurs. At present, it is considered that polyamines are a good indicator as an auxiliary diagnosis and efficacy observation of malignant tumors. Materials and Methods 1. Measurements: The control group consisted of 33 female health care workers in our hospital aged 19-53 years. The observation group consisted of 42 breast cancer patients, all of whom were female. All patients were confirmed by clinical, cytological, and pathological sections and were 31 to 61 years old.